M42 has partnered with the Great Ormond Street Hospital for Children (GOSH) to introduce an education initiative that aims to enhance pediatric critical and complex care in the Middle East, with an initial focus on M42’s Danat Al Emarat Hospital for Women and Children.

The multifaceted collaboration aims to support children with complex medical conditions in the initial phase through education programmes, with a vision to extend the partnerships to include genomics and research, to advance genomics, and cell and gene therapy. GOSH has a long-standing relationship with the UAE and is home to the Zayed Centre for Research into Rare Disease in Children, which opened in 2019.

Ashish Koshy, Group Chief Operating Officer of M42, said: “Through collaborations such as this, M42 is impactfully disrupting global health. We see our partnership with Great Ormond Street Hospital as an opportunity to take pediatric health to a new level in the region and reset best practices globally. By combining GOSH’s world-class solutions with M42’s innovative health solutions, we are positioning ourselves to really make a difference. Further strengthening M42’s clinical operations, and reshaping excellence for children’s health.”

Christopher Rockenbach, Director of International and Commercial at Great Ormond Street Hospital for Children, said: “We are proud of our long-standing relationship with the UAE and excited to be strengthening our commitment to the region with such an esteemed partner as M42. We look forward to contributing to improving children's health through this collaboration.” 

Lynn Shields, Director of Education at Great Ormond Street Hospital Learning Academy, said: “Education underpins everything we do at GOSH. In collaborating with M42, we have a unique opportunity to significantly impact pediatric healthcare by sharing our knowledge and expertise and delivering outstanding, targeted educational programmes.”

Omar Al Naqbi, Acting Executive Director at Danat Al Emarat Hospital for Women and Children, said: “We're thrilled to be exploring such an exciting collaboration with GOSH. GOSH is recognised all over the world for the incredible standards of care it delivers. This collaboration is a testament to our commitment to the children of the UAE, ensuring they have access to the best care possible. It also highlights our dedication to ensuring our clinical teams continue to develop professionally and provide the highest level and standards of clinical care."

The collaboration seeks to streamline patient care, through the establishment of a robust joint Multidisciplinary Team (MDT) approach between Danat Al Emarat and GOSH, a second opinion framework and a visiting consultant programme. With Level 3 Neonatal Intensive Care Unit (NICU) and Pediatric Intensive Care Unit (PICU) facilities at Danat Al Emarat Hospital, the partnership with GOSH helps to enhance the quality of pediatric and neonatal critical care. The initiative will also focus on enhancing the skills of the hospital’s PICU and NICU staff. GOSH will provide expert clinical training programmes, including participation in GOSH Grand Rounding to facilitate shared learning and continued education.

The collaboration will also explore numerous research and innovation projects including advancing genomics, and pioneering cell and gene therapy approaches, which aligns with M42’s role as the facilitator of the Emirati Genome Programme in the UAE. Other areas of exploration may include machine learning and AI, such M42's generative AI language model, Med42.  

The agreement was signed by Ashish Koshy, Group Chief Operating Officer of M42, and Christopher Rockenbach, Managing Director of International and Commercial, Great Ormond Street Hospital for Children NHS Foundation Trust.